Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM

Historically, myeloablative allogeneic hematopoietic SCT (HSCT) has required prolonged in-patient hospitalization due to the effects of mucosal toxicity and prolonged cytopenias. We explored the safety and feasibility of outpatient management of these patients. A total of 100 consecutive patients un...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2010-03, Vol.45 (3), p.468-475
Hauptverfasser:	Solomon, S R, Matthews, R H, Barreras, A M, Bashey, A, Manion, K L, McNatt, K, Speckhart, D, Connaghan, D G, Morris, L E, Holland, H K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Ambulatory Care Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow, stem cells transplantation. Graft versus host reaction Care and treatment Cell Biology Complications Female Fever Graft Survival Graft vs Leukemia Effect Hematologic Neoplasms - therapy Hematology Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic stem cells Hospital care Hospitalization Humans Infection - etiology Internal Medicine Kaplan-Meier Estimate Length of Stay Leukemia Male Malignancy Medical sciences Medicine Medicine & Public Health Middle Aged Morbidity Mortality Mucosa Myeloablative Agonists - therapeutic use Neutropenia original-article Patient outcomes Patients Prevention Public Health Risk factors Stem cell transplantation Stem Cells Toxicity Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation Conditioning Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!